5 Followers on Owler

ImmunoMet

ImmunoMet is a Texas-based biotechnology company that develops and commercializes therapies for the treatment of cancer and fibrosis diseases. Read more

Benjamin R. Cowen's photo - President & CEO of ImmunoMet

President & CEO

Benjamin R. Cowen

CEO Approval Rating

70/100

Founded:

2008

Status:

PrivateIndependent Company

Est. Annual Revenue
Est. Employees

IMMUNOMET TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

NexImmune is ImmunoMet's top competitor. NexImmune is headquartered in Gaithersburg, Maryland, and was founded in 2011. Like ImmunoMet, NexImmune also operates in the Biotechnology field. NexImmune generates NaN% the revenue of ImmunoMet.

TScan is seen as one of ImmunoMet's top competitors. TScan's headquarters is in Waltham, Massachusetts, and was founded in 2018. Like ImmunoMet, TScan also works within the Biotechnology industry. TScan generates ∞% of ImmunoMet's revenue.

Tmunity has been one of ImmunoMet's top competitors. Tmunity was founded in 2015, and its headquarters is in Philadelphia, Pennsylvania. Like ImmunoMet, Tmunity also works within the Biotechnology field. Tmunity has 110 fewer employees than ImmunoMet.

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is 200 a good estimate for ImmunoMet's Employee count?

ImmunoMet Acquisitions

No recent acquisitions found related to ImmunoMet

ImmunoMet Funding History

Since ImmunoMet was founded in 2008, it has participated in 4 rounds of funding. In total ImmunoMet has raised $25.8M. ImmunoMet's last funding round was on Feb 2021 for a total of $7.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Equity
Feb 2021
$7M
-
Convertible Note
May 2018
$8.6M
-
Series B
Mar 2017
$5M
Series A
Mar 2016
$5.2M
-

Since ImmunoMet was founded in 2008, it has participated in 4 rounds of funding. In total ImmunoMet has raised $25.8M. ImmunoMet's last funding round was on Feb 2021 for a total of $7.0M

ImmunoMet Investments

No recent investments found related to ImmunoMet

ImmunoMet News

November 29, 2017Post Online Media

ImmunoMet Therapeutics appoints two directors

November 29, 2017, Houston, Tx., USA - ImmunoMet Therapeutics, a private biotechnology company, annou... See more »
March 16, 2017BioPortfolio

ImmunoMet Raises $5M in Series B Financing

NewsThe Company's lead molecule IM156 an OXPHOS inhibitor is expected to enter a Phase 1 clinical tri... See more »
March 8, 2017FierceBiotechIT

Cash injection sets up first trial of ImmunoMet's lead cancer metabolism drug

Cash injection sets up first trial of ImmunoMet's lead cancer metabolism drug phil Wed, 03/08/2017 - ... See more »
March 6, 2017The Business Journals: Houston

Houston cancer company raises $5 million to fund clinical trials

A Houston-based cancer-fighting company has raised a $5 million Series B round from Korean investors ... See more »
March 14, 2016BioPortfolio

Korea's ImmunoMet raises $5.2 mn

Biospectrum The primary use of these proceeds will be to fund the company's research and clinical dev... See more »

ImmunoMet Press Releases

Social Media

ImmunoMet Headquarters

2450 Holcombe Blvd

Houston, Texas77021

346-772-0318

Driving Directions »

Trending Companies

ImmunoMet Summary

ABOUT

Overview

ImmunoMet is a Texas-based biotechnology company that develops and commercializes therapies for the treatment of cancer and fibrosis diseases. ImmunoMet was founded in 2008. ImmunoMet's headquarters is located in Houston, Texas, USA 77021. It has rais...

CEO

ImmunoMet's President & CEO, Benjamin R. Cowen, currently has an approval rating of 70%. ImmunoMet's primary competitors are NexImmune, TScan & Tmunity.

Frequently Asked Questions about ImmunoMet

  1. When was ImmunoMet founded?

    ImmunoMet was founded in 2008
  2. Who is ImmunoMet's CEO?

    ImmunoMet's CEO is Benjamin R. Cowen
  3. How much revenue does ImmunoMet generate?

    ImmunoMet generates $ < 1M in revenue
  4. How much funding does ImmunoMet have?

    ImmunoMet has historically raised $25.8M in funding
  1. Where is ImmunoMet's headquarters?

    ImmunoMet's headquarters is in Houston Texas, USA
  2. How many employees does ImmunoMet have?

    ImmunoMet has 200 employees
  3. What sector does ImmunoMet operate in?

    ImmunoMet is in Biotechnology
  4. Who are ImmunoMet's competitors?

    ImmunoMet's top competitors are NexImmune, TScan, Tmunity